LSC
Lyon Street Capital Portfolio holdings
AUM
$67M
This Quarter Return
+5.38%
1 Year Return
–
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$281M
AUM Growth
-$29.3M
(-9.4%)
Cap. Flow
-$35.3M
Cap. Flow
% of AUM
-12.54%
Top 10 Holdings %
Top 10 Hldgs %
54.92%
Holding
62
New
12
Increased
11
Reduced
29
Closed
10
Top Buys
| 1 |
SBBP
Strongbridge Biopharma plc.
SBBP
|
+$8.3M |
| 2 |
SGI
Somnigroup International Inc.
SGI
|
+$6.68M |
| 3 |
STML
Stemline Therapeutics, Inc.
STML
|
+$3.7M |
| 4 |
QuinStreet
QNST
|
+$3.31M |
| 5 |
QTNA
Quantenna Communications, Inc. Common Stock
QTNA
|
+$2.85M |
Top Sells
| 1 |
BFYT
Benefytt Technologies, Inc. Class A Common Stock
BFYT
|
+$7.95M |
| 2 |
BEAT
BioTelemetry, Inc.
BEAT
|
+$5.78M |
| 3 |
RSPP
RSP Permian, Inc.
RSPP
|
+$5.1M |
| 4 |
CARB
Carbonite Inc
CARB
|
+$4.56M |
| 5 |
MCHB
Mechanics Bancorp Class A Common Stock
MCHB
|
+$4.18M |
Sector Composition
| 1 | Healthcare | 37.98% |
| 2 | Technology | 19.74% |
| 3 | Financials | 13.45% |
| 4 | Communication Services | 8.08% |
| 5 | Industrials | 5.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CURO
51
DELISTED
CURO Group Holdings Corp.
CURO
| $583K | 0.21% |
+23,367
| New | +$583K |
|
52
Franklin Covey
FC
$245M
| $377K | 0.13% |
+15,363
| New | +$377K |
|
|
CNCE
53
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| – | – |
-11,893
| Closed | -$272K |
|
|
NTUS
54
DELISTED
Natus Medical Inc
NTUS
| – | – |
-17,636
| Closed | -$593K |
|
|
IMMU
55
DELISTED
Immunomedics Inc
IMMU
| – | – |
-252,855
| Closed | -$3.69M |
|
|
RSPP
56
DELISTED
RSP Permian, Inc.
RSPP
| – | – |
-108,693
| Closed | -$5.1M |
|
57
Herbalife
HLF
$961M
| – | – |
-36,000
| Closed | -$1.75M |
|
|
MCHB
58
Mechanics Bancorp Class A Common Stock
MCHB
$3.07B
| – | – |
-145,922
| Closed | -$4.18M |
|
59
Ionis Pharmaceuticals
IONS
$10.2B
| – | – |
-69,554
| Closed | -$3.07M |
|
60
Lesaka Technologies
LSAK
$345M
| – | – |
-249,268
| Closed | -$2.36M |
|
61
Twilio
TWLO
$15.7B
| – | – |
-30,500
| Closed | -$1.16M |
|
62
UroGen Pharma
URGN
$888M
| – | – |
-32,841
| Closed | -$1.63M |
|